BIOCRYST PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Biocryst Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14M, a 61.2% increase year-over-year.
  • Biocryst Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$124M, a 47.6% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$227M, a 8.33% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$247M, a 34.3% decline from 2021.
  • Biocryst Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$184M, a 0.68% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$227M +$20.6M +8.33% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$247M -$63.1M -34.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$184M -$1.25M -0.68% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$183M -$73.9M -67.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$109M -$7.65M -7.55% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$101M -$35.5M -53.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$65.8M -$10.6M -19.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 -$55.1M -$12.1M -28.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$43M +$2.17M +4.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$45.2M -$15.1M -50.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 -$30.1M +$8.97M +23% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$39.1M +$17.9M +31.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$56.9M -$23.1M -68.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-10
2010 -$33.9M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.